What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Health care
Erkka Valovirta mainly focuses on Allergy, Immunology, Asthma, Randomized controlled trial and Quality of life.
His Allergy study which covers Chronic disease that intersects with Severity of illness, Surgery, Pediatric asthma and Developed country.
His Immunology research integrates issues from Odds ratio, Internal medicine, Position paper and Intensive care medicine.
His research integrates issues of Guideline, Medical history, Pediatrics and Family medicine in his study of Asthma.
His Randomized controlled trial research incorporates elements of Immunoglobulin E, Placebo-controlled study and Immunotherapy.
Erkka Valovirta has included themes like Integrated care, Health care, Disease management and Physical therapy in his Quality of life study.
His most cited work include:
- Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. (712 citations)
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision (480 citations)
- Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report (463 citations)
What are the main themes of his work throughout his whole career to date?
Erkka Valovirta focuses on Asthma, Allergy, Immunology, Family medicine and Pediatrics.
His Asthma research includes themes of Quality of life, Randomized controlled trial, Quality of life, Intensive care medicine and Disease.
Erkka Valovirta focuses mostly in the field of Allergy, narrowing it down to matters related to Internal medicine and, in some cases, Placebo.
His Immunology study typically links adjacent topics like Odds ratio.
Within one scientific family, Erkka Valovirta focuses on topics pertaining to Health care under Family medicine, and may sometimes address concerns connected to Guideline.
The Pediatrics study combines topics in areas such as Hay fever and Anti-asthmatic Agent.
He most often published in these fields:
- Asthma (50.35%)
- Allergy (47.55%)
- Immunology (27.97%)
What were the highlights of his more recent work (between 2017-2021)?
- Asthma (50.35%)
- Allergy (47.55%)
- Internal medicine (11.19%)
In recent papers he was focusing on the following fields of study:
Asthma, Allergy, Internal medicine, Randomized controlled trial and Visual analogue scale are his primary areas of study.
His Asthma research includes elements of mHealth, Observational study, Quality of life, Intensive care medicine and Physical therapy.
His Allergy study integrates concerns from other disciplines, such as Patient participation, Family medicine and Medical record.
His Internal medicine research focuses on Placebo and how it connects with Tolerability.
Erkka Valovirta interconnects Clinical decision support system, Allergen and Clinical trial in the investigation of issues within Randomized controlled trial.
Erkka Valovirta combines subjects such as Alternative medicine, Multimorbidity and Gerontology with his study of Visual analogue scale.
Between 2017 and 2021, his most popular works were:
- MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence (56 citations)
- Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. (54 citations)
- The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study (52 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Health care
- Disease
His scientific interests lie mostly in Asthma, Visual analogue scale, Allergy, mHealth and Randomized controlled trial.
His Asthma study combines topics in areas such as Guideline, Observational study and Health care.
His research in Visual analogue scale intersects with topics in Internal medicine and Quality of life.
His mHealth research is multidisciplinary, incorporating perspectives in Allergen, Intensive care medicine, Pharmacotherapy, Disease and Health literacy.
The various areas that Erkka Valovirta examines in his Randomized controlled trial study include Physical therapy and Azelastine.
His Physical therapy research is multidisciplinary, relying on both Quality of life and Fluticasone propionate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
